Valuation StemCell Institute Inc.

Stocks

Market Closed - Japan Exchange 10:30:00 13/11/2026 +04			5-day change	1st Jan Change
651.00 ^JPY	-3.98%		+1.88%	-17.91%

01/08/25	Tranche Update on StemCell Institute Inc.'s Equity Buyback Plan announced on December 17, 2024.	CI
31/07/25	StemCell Institute Inc.'s Equity Buyback announced on December 17, 2024, has closed with 176,300 shares, representing 1.73% for ¥199.94 million.	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2026	2027	2028
Market Cap ¹	6,556	-	-
Change	-	-	-
Enterprise Value (EV)	5,352	6,556	6,556
Change	-	0%	0%
P/E	49.6x	82.4x	19.3x
PBR	2.88x	2.17x	2.18x
PEG	-	-1.5x	0x
Capitalization / Revenue	2.74x	2.25x	1.9x
EV / Revenue	0x	2.25x	1.9x
EV / EBITDA	0x	24.3x	10.1x
EV / EBIT	0x	72.8x	14.6x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	15.44	7.9	33.8
Distribution rate	-	-	-
Net sales ¹	2,811	2,920	3,450
EBITDA ¹	359.4	270	650
EBIT ¹	202	90	450
Net income ¹	155	80	340
Net Debt	-2,362	-	-
Reference price ²	651.00	651.00	651.00
Nbr of stocks (in thousands)	10,070	-	-
Announcement Date	13/05/26	-	-

¹JPY in Million²JPY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
STEMCELL INSTITUTE INC.	-	-	-	-	41M
CVS HEALTH CORPORATION	12.75x	0.4x	8.06x	2.96%	114B
HCA HEALTHCARE, INC.	16.49x	1.96x	9.75x	0.63%	104B
NATERA, INC.	-204.97x	15.01x	-229.6x	-.--%	46.27B
FRESENIUS SE & CO. KGAA	16.74x	1.72x	10.34x	2.21%	33.33B
LABCORP HOLDINGS INC.	27.25x	2.38x	13.49x	0.79%	30.08B
QUEST DIAGNOSTICS INCORPORATED	25.15x	2.78x	14.1x	1.27%	28.56B
TENET HEALTHCARE CORPORATION	7.86x	1.51x	6.61x	-.--%	22.76B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	29.46x	5.34x	21.71x	2.37%	19.92B
IHH HEALTHCARE	30.68x	2.88x	12.97x	1.44%	17.15B
Average	-4.29x	3.77x	-14.73x	1.3%	42B
Weighted average by Cap.	-7.01x	3.22x	-16.15x	1.46%